Analysis of the relationship between comorbid obstructive sleep apnea and clinical outcomes in patients with asthma in Japan

• Published in: Allergology international Vol. 73; no. 3; pp. 390 - 396
• Main Authors: Ikegami-Tanaka, Hitomi, Yasokawa, Naoya, Kurose, Koji, Tajima, Shonosuke, Abe, Masaaki, Katoh, Shigeki, Kobashi, Yoshihiro, Oga, Toru
• Format: Journal Article
• Language: English
• Published: England Elsevier B.V 01-07-2024; Elsevier
• Subjects: Adult; Aged; Asthma; Asthma - complications; Asthma - diagnosis; Asthma - epidemiology; Asthma control test; BMI; Comorbidity; Female; Humans; Japan - epidemiology; Leicester cough questionnaire; Male; Middle Aged; Obstructive sleep apnea; Respiratory Function Tests; Severity of Illness Index; Sleep Apnea, Obstructive - complications; Sleep Apnea, Obstructive - diagnosis; Sleep Apnea, Obstructive - epidemiology; Japan; SpO2; Leicester cough questionnaire; AHQ; Obstructive sleep apnea; Asthma; GERD; ACT; FVC; Asthma control test; ODI; CAT; REI; LCQ; OSA; PSQI; BMI
• ISSN: 1323-8930; 1440-1592; 1440-1592
• DOI: 10.1016/j.alit.2024.01.009

Asthma and obstructive sleep apnea (OSA) are prevalent chronic respiratory disorders, which often coexist and interact with each other. Obesity is an important risk factor shared by them. The rate of obesity is lower in Japan versus Western countries. Hence, the co-existence of asthma and OSA has not been investigated in Japan.
Ninety-seven outpatients with asthma were recruited. Patients wore a portable monitor for sleep study. Background data, pulmonary function, blood tests, and patient-reported outcomes including gastroesophageal reflux disease, sleepiness, sleep quality, asthma control, cough and respiratory symptoms, and health status, were assessed.
Of the patients, 19 (19.6 %), 40 (41.2 %), 24 (24.7 %), and 14 (14.4 %) were classified into non-, mild, moderate, and severe OSA groups. Non-OSA patients were younger than those in other groups (p < 0.05). The BMI of patients with moderate and severe OSA, was higher than that of non-OSA patients (p < 0.05). Pulmonary function, FeNO, serum IgE, and the number of peripheral eosinophils were not significantly different between groups. Nonetheless, compared with the other groups, treatment step was the highest, and the Asthma Control Test, Leicester Cough Questionnaire, COPD Assessment Test, and Asthma Health Questionnaire-33 yielded worst scores in the severe OSA group, and predicted the severe OSA after adjustment by BMI.
Moderate and severe OSA are highly prevalent among patients with asthma in Japan. Pulmonary function did not differ between groups. However, patients with asthma and severe OSA were linked to more asthma treatment, worse asthma control, more symptoms and cough, and worse health status.